Evidence-Based Clinical Practice Guidelines for the Management of Substance Use Disorders

The VA/DoD Clinical Practice Guideline updated in 2015 addresses many of the critical decision points in the Management of Substance Use Disorders among adults. The guideline incorporates findings from a systematic review of empirical literature and other decision domains by the guideline development panel to support actionable recommendations that can inform shared decision making by patients and providers to promote individualized care. This program presented by Daniel Kivlahan, PhD, and hosted by Bruce Liese, PhD, discusses the overview of the guideline recommendations and how they were developed, including discussion of some of the gaps in the evidence base and selected clinical challenges.

This product is not included in the APA Unlimited CE program.

• Describe at least four of the clinically important topics that provide a context for substance use disorder care delivery that are not covered in the systematic review or by the evidence-based recommendations.
• Identify at least one clinical decision about psychosocial treatment and one about pharmacotherapy for which the guideline development panel found insufficient evidence to recommend for or against a treatment approach.
• Explain advantages and challenges of measurement based care for individualizing treatment and promoting improved outcomes.

This Continuing Education program is in collaboration with the APA Science, the APA Center for Learning and Career Development, the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholismopens in new window and the Society of Addiction Psychology (Division 50 of APA).